PASS Updates Mgen Guidance, Requires Testing by Oct. 1

PASS Updates Mgen Guidance, Requires Testing by Oct. 1

LOS ANGELES — PASS has revised its guidance for Mycoplasma genitalium (Mgen), and will require testing by Oct. 1.

The PASS statement follows:

The PASS Medical Advisory Board met last month in part to discuss the current impact of Mycoplasma genitalium, “Mgen”, on the adult industry. The science on Mgen is not settled, research is ongoing with new developments regularly occurring. Here’s what we do know:

• Many cases of Mgen are asymptomatic. The current evidence suggests that potential complications from asymptomatic infections are rare, however, it is still possible to transmit cases that could cause symptoms in other people.

• Some cases of Mgen cases will resolve on their own but studies have shown wide ranges of timeframes for natural clearance (could be several weeks to months).

• The bacteria is slow to grow, which makes transmission and testing timelines difficult to know. Testing may identify infections that are no longer active, and are no longer a threat, for weeks or even months later.

This presents a challenge because it means that testing alone is not the answer. If we test everyone for Mgen with the same frequency as other infections, we’re likely to identify a significant percentage of those who test positive may not have needed any or additional treatment. And if we treat all of those people, there may be a significant risk of creating a drug-resistant strain of Mgen in our community. There is no current evidence that frequent testing will result in better health outcomes.

This is a complex problem that needs coordinated solutions that go beyond testing. While it will not be easy, the PASS is already working with testing centers, infectious disease specialists, laboratory diagnosticians, public health experts and people within the community to effectively address the issue. In the coming weeks, we’ll continue to adapt solutions and be transparent about the process. In the meantime, we are implementing the following actions:

• To be eligible for clearance in PASS, we will request everyone be tested by October 1, 2023. All tests during the month of September will be eligible.

• PASS is working to implement a volunteer contact tracing program to help identify, isolate, and treat the spread of Mgen infections within our community which we will be rolling out within the next week.

• Helping people get appropriate treatment through programs and educational campaigns. Successful treatment, including taking all medicine as prescribed by your clinician, is essential to preventing drug resistance. Current CDC treatment guidelines for Mgen is Doxycycline 100 mg orally 2 times/day for 7 days, followed by moxifloxacin 400 mg orally once daily for 7 days.

PASS strongly advises against requiring Mgen testing as part of regular 14-day work clearance. We wish the solution were as simple as adding an additional test. Unfortunately, in the case of Mgen, the harms may outweigh the benefits — both individually and as a community. Our goal with the plan we have laid out is to reduce the prevalence of Mgen within our community while minimizing the development of antimicrobial resistance and unnecessary financial impact to talent.

However, anyone who is experiencing symptoms or who has had sex with someone who has tested positive for Mgen should get tested. Mgen testing is currently available at all PASS Certified testing partners.

We know many of you are frustrated and scared. It is our responsibility as an organization, as health experts, to provide a clear head in times of fear and confusion. We don’t know all the answers, but no one does — especially not about our community. We will be in contact in the coming days and weeks to share what we know and update any guidance.

For more information, visit PassCertified.com.

Related:  

Copyright © 2025 Adnet Media. All Rights Reserved. XBIZ is a trademark of Adnet Media.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.

More News

Brittney Kade Headlines Latest From TransSensual

Brittney Kade stars in "Sweat Slut Licks Pretty Pits for Bear Fuck," from TransSensual.

Sweet Sinner Releases 7th Volume of 'The Hot Wives'

Kenzie Taylor, Little Puck, Blake Blossom, and Sophia Locke star in the seventh volume of "The Hot Wives," from Mile High Media studio imprint Sweet Sinner.

Leilani Li, Angellica Good Star in Latest From TransAngels

Leilani Li and Angellica Good star in the latest release from TransAngels, titled “Double VR Mouth Swap,” alongside Marcus McNeill.

Ember Snow Performs 1st DP in Latest From Pure Taboo

Ember Snow has performed her first DP alongside multi-XMAs winner Seth Gamble and Vince Karter in a new psychological thriller release from Pure Taboo, titled “Locked in a Nightmare.”

Savvy Suxx Is Hustler's 'Cover Honey' for August

Savvy Suxx is the Cover Honey for the August issue of Hustler Magazine and appears in a 14-page centerfold spread shot by ThisYearsModel.com.

Payton Preslee Toplines Latest From Hard X

Payton Preslee headlines "Sexual Icons 4," from XEmpire studio brand Hard X.

XBIZ Amsterdam Calls on New Startups for 'Spotlight' Program

XBIZ is pleased to announce that its new “Startup Spotlight” programming will make its European premiere at XBIZ Amsterdam 2025, set to take place Sept. 2-5 at the Jakarta Hotel Amsterdam.

Nadia Jay Stars in Latest From Brazzers

Nadia Jay stars with Mick Blue in the latest release from Brazzers, titled "Fucking the Bath Voyeur."

Tommy Gunn Reflects on His Legendary Past as He Looks to the Future

Tommy Gunn is wearing an eyepatch. It’s not an homage to the classic "Pirates" porn parody franchise, in which Gunn takes on the Johnny Depp role. The eyepatch is a temporary measure to help him deal with a nerve palsy that came out of nowhere several years ago and affects his vision from time to time. Gunn needs his vision. As one of the adult industry’s longest-serving male stars, he still has plenty to look forward to.

Rocco Siffredi Directs New Rebel Rhyder Showcase

Evil Angel has released Rocco Siffredi’s Rebel Rhyder showcase title, "Rebel Meets Rebel."

Show More